Novo Nordisk Aktie
50,82
EUR
+1,50
EUR
+3,04
%
50,83
EUR
+1,43
EUR
+2,89
%
Werbung
Novo Nordisk Aktie Analyse
| 30.11.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 07.11.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.11.16 | Novo Nordisk buy | Deutsche Bank AG | |
| 31.10.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 27.10.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 30.09.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 16.09.16 | Novo Nordisk buy | Citigroup Corp. | |
| 14.09.16 | Novo Nordisk Outperform | BNP PARIBAS | |
|
Werbung
|
|||
| 05.09.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 02.09.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 02.09.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 22.08.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 09.08.16 | Novo Nordisk buy | Citigroup Corp. | |
| 09.08.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 08.08.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 02.08.16 | Novo Nordisk buy | Citigroup Corp. | |
| 01.08.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 27.07.16 | Novo Nordisk buy | Citigroup Corp. | |
| 25.07.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 13.07.16 | Novo Nordisk overweight | Morgan Stanley | |
| 13.07.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.06.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.06.16 | Novo Nordisk buy | Citigroup Corp. | |
| 15.06.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 14.06.16 | Novo Nordisk buy | Citigroup Corp. | |
| 14.06.16 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
| 13.06.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 09.06.16 | Novo Nordisk overweight | Morgan Stanley | |
| 09.06.16 | Novo Nordisk buy | Baader Wertpapierhandelsbank | |
| 26.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 26.05.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 04.05.16 | Novo Nordisk buy | Citigroup Corp. | |
| 03.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 02.05.16 | Novo Nordisk overweight | Barclays Capital | |
| 29.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 26.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.04.16 | Novo Nordisk overweight | Morgan Stanley | |
| 18.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.03.16 | Novo Nordisk overweight | Morgan Stanley | |
| 07.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 07.03.16 | Novo Nordisk overweight | Morgan Stanley | |
| 07.03.16 | Novo Nordisk buy | Citigroup Corp. | |
| 07.03.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.03.16 | Novo Nordisk buy | Citigroup Corp. | |
| 24.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 15.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.02.16 | Novo Nordisk overweight | Barclays Capital | |
Werbung
Werbung